These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

401 related items for PubMed ID: 29223956

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Primary Prevention With Statins: ACC/AHA Risk-Based Approach Versus Trial-Based Approaches to Guide Statin Therapy.
    Mortensen MB, Afzal S, Nordestgaard BG, Falk E.
    J Am Coll Cardiol; 2015 Dec 22; 66(24):2699-2709. PubMed ID: 26700832
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER)--can C-reactive protein be used to target statin therapy in primary prevention?
    Mora S, Ridker PM.
    Am J Cardiol; 2006 Jan 16; 97(2A):33A-41A. PubMed ID: 16442935
    [Abstract] [Full Text] [Related]

  • 26.
    Lozano P, Henrikson NB, Dunn J, Morrison CC, Nguyen M, Blasi PR, Anderson ML, Whitlock E.
    ; 2016 08 16. PubMed ID: 27559556
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Association of lecithin-cholesterol acyltransferase activity and low-density lipoprotein heterogeneity with atherosclerotic cardiovascular disease risk: a longitudinal pilot study.
    Yokoyama K, Tani S, Matsuo R, Matsumoto N.
    BMC Cardiovasc Disord; 2018 Dec 05; 18(1):224. PubMed ID: 30518338
    [Abstract] [Full Text] [Related]

  • 29. Association of triglyceride-rich lipoproteins-related markers and low-density lipoprotein heterogeneity with cardiovascular risk: effectiveness of polyacrylamide-gel electrophoresis as a method of determining low-density lipoprotein particle size.
    Tani S, Matsumoto M, Nagao K, Hirayama A.
    J Cardiol; 2014 Jan 05; 63(1):60-8. PubMed ID: 24016623
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Triglyceride-rich lipoproteins, apolipoprotein C-III, angiopoietin-like protein 3, and cardiovascular events in older adults: Atherosclerosis Risk in Communities (ARIC) study.
    Hussain A, Sun C, Selvin E, Nambi V, Coresh J, Jia X, Ballantyne CM, Hoogeveen RC.
    Eur J Prev Cardiol; 2022 Mar 11; 29(2):e53-e64. PubMed ID: 33580780
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Effects of low dose oral contraceptives on very low density and low density lipoprotein metabolism.
    Walsh BW, Sacks FM.
    J Clin Invest; 1993 May 11; 91(5):2126-32. PubMed ID: 8486779
    [Abstract] [Full Text] [Related]

  • 38. Association of plasminogen activator inhibitor-1 and low-density lipoprotein heterogeneity as a risk factor of atherosclerotic cardiovascular disease with triglyceride metabolic disorder: a pilot cross-sectional study.
    Iida K, Tani S, Atsumi W, Yagi T, Kawauchi K, Matsumoto N, Hirayama A.
    Coron Artery Dis; 2017 Nov 11; 28(7):577-587. PubMed ID: 28692480
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Small Dense Low-Density Lipoprotein Cholesterol Is the Most Atherogenic Lipoprotein Parameter in the Prospective Framingham Offspring Study.
    Ikezaki H, Lim E, Cupples LA, Liu CT, Asztalos BF, Schaefer EJ.
    J Am Heart Assoc; 2021 Feb 11; 10(5):e019140. PubMed ID: 33586462
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.